Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DCGI gives nod to phase-I clinical trial of COVID-19 vaccine by Reliance Life Sciences
The trials will be conducted at eight sites in Maharashtra
TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid
Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…
Dr Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals to sell its…
In March 2016, Dr Reddy’s had acquired the exclusive global rights (excluding Japan and Asia) to the investigational anti-cancer…
Risk Assessment for extractables/leachables for single-use technologies implementation in the wake…
2nd September 2021 | 11:00 AM - 12:30 PM IST | Live Webinar
Takeda’s phase-III Panther trial unable to achieve primary endpoint of event-free survival
The trial evaluated whether the combination of pevonedistat plus azacitidine as first-line treatment for patients with higher-risk…
AstraZeneca reaches settlement with EU on COVID-19 vaccine delivery
About 92 million doses of AstraZeneca's vaccine have been distributed to EU member states so far, according to the European Centre…
Pfizer starts phase-III clinical trial in adults for investigational vaccine against RSV
First subjects vaccinated in study of Pfizer’s RSV bivalent prefusion F subunit investigational vaccine candidate in adults aged…
Abbott expands peripheral vascular offerings, acquires Walk Vascular
The acquisition builds upon Abbott's leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with…
Granules India gets licence from DRDO to manufacture and market COVID-19 drug 2-DG
Developed by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adjunct…
Dr Reddy’s launches Reddy-Lenalidomide in Canada
It is one of the first generic medications of its kind for the Canadian market